BARCELONA, Spain and PHILADELPHIA, May 15, 2012 /PRNewswire/ --
Cloud-based Veeva CRM Now Deployed in Over 20 European Countries
With its 4th Annual Global Customer Summit kicking off this morning in Philadelphia, Veeva Systems announced dramatic growth of cloud-based Veeva CRM throughout the continent. Since Veeva's official expansion into Europe in April 2010, the company has delivered the advantages of cloud computing to more than 35 life sciences companies across 20+ different European markets. When all current deployments are complete, there will be over 30,000 European pharmaceutical representatives using Veeva CRM to better manage their relationships with customers. To support its large user base, Veeva has opened major offices in Barcelona, Budapest and Paris and, along with a network of strategic partners, currently has more than 200 certified Veeva Administrators to implement and support the cloud-based CRM solution in Europe.
Veeva's European customers include dozens of emerging biotechs and specialty companies as well as ten of the Top 20 global pharmaceutical companies. Key global customers include Astellas Pharma, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, and Novartis; key specialty leaders include Actelion, Grünenthal, LEO Pharma, and Stallergenes; and small and medium-sized customers include Human Genome Sciences, Iroko Cardio, Mundipharma, and Pharco Pharma.
"Winning in today's challenging European pharmaceutical environment requires a fundamentally different commercial approach. To support our new commercial model, we wanted a CRM solution that was truly pan-European, future-proof and agile enough to grow with our organisational needs. Veeva CRM was the only solution to meet all these business requirements," said Wim Kockelkoren, senior vice president EMEA Commercial Effectiveness and CEE Region, Aste
|SOURCE Veeva Systems|
Copyright©2010 PR Newswire.
All rights reserved